SCHEMBL4756285

SCHEMBL4756285

CCS(=O)(=O)Oc1cc(C(=O)Nc2ncc(Cl)s2)ccc1SC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.41
KDR P35968 1/20 0.41
IDH2 P48735 1/20 0.40
FFAR2 O15552 1/20 0.40
SCD O00767 7/20 0.40
KDM4E B2RXH2 2/20 0.39
STAT3 P40763 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRSS12 P56730 2/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 1/20 0.38
ALOX15 P16050 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755989 0.78 SMN1; SMN2 (0.48) SCDKDM4ESTAT3MEN1KMT2A
SCHEMBL4295245 0.66 ADORA2A (0.53) FFAR2STAT3MEN1KMT2ANPC1
SCHEMBL4297883 0.65 ALOX15 (0.58) CDK2KDRFFAR2SCDKDM4E
SCHEMBL4292854 0.65 ADORA2A (0.63) MEN1KMT2ASMN1; SMN2L3MBTL1NPC1
SCHEMBL4293155 0.64 STAT3 (0.64) SCDKDM4ESTAT3MEN1KMT2A
SCHEMBL4292546 0.62 KDR (0.59) CDK2KDRSCDKDM4EMEN1
SCHEMBL19351675 0.62 STAT3 (0.42) KDM4ESTAT3MEN1KMT2ASMN1; SMN2
SCHEMBL22155012 0.62 LMNA (0.39) STAT3MEN1KMT2ASMN1; SMN2HTT
SCHEMBL4756006 0.62 SCD (0.51) CDK2SCDKDM4ESMN1; SMN2HTT
SCHEMBL4290822 0.62 ADORA2A (0.64) CDK2FFAR2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC CDK2 200/4885KDR 4456/4885IDH2 1174/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC CDK2 200/4885KDR 4456/4885IDH2 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.